Quarterly Lecture

Due to an unforeseen conflict our December Quarterly will need to be postponed to

January 8, 2019


A Deeper Response:  MRD-Negativity Results for 

Pre-B Acute Lymphoblastic Leukemia Patients Receiving Blinatumomab”

Christine Rimkus CNS-BC, MSN AOCN

Center for Blood and Marrow Outpatient Transplant,

SSM Health St. Louis University Hospital

Sponsored by
Screen Shot 2018-05-12 at 5.40.19 PM





  1. Understand the use of Blinatumomab (Blincyto) in the treatment of relapsed Pre-B Acute Lymphoblastic Leukemia.
  2. Describe the mechanism of action, dosing and administration, and important side effects for Blinatumomab for safe monitoring of patients receiving this type of immunotherapy.
  3. Discuss the patient/family education required to receive this agent in the outpatient setting.



Claim Jumper Restaurant

18050 Brookhurst Street Fountain Valley, CA 92708

Phone: (714) 963-6711

Parking is free and readily available


Upcoming Quarterly Lectures

March 12, 2019

December 10, 2019




Lecture Registration